Cassava Sciences Inc (NASDAQ:SAVA) currently has a daily average trading volume of 3.29M but it saw 1038220 shares traded in last market. With a market cap of 1.41B USD, the company’s current market price of $29.45 came falling about -0.77 while comparing to the previous closing price of $29.68. In past 52 weeks, the stock remained buoying in the range of price level as high as $42.20 and as low as $8.79. In the recent trading on the day, stock has struck highest price mark of $28.66 while lowest mark touched by it was $30.899.
Taking a look at 20-day trading activity of Cassava Sciences Inc (SAVA) gives us an average price of $27.82, while its current price level is -30.21% below from 52-week high level whereas it is 235.04% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $20.65 while that of 200 days or SMA-200 reads an average of $22.06. A closer look into the stock’s movement over the week reveals that its volatility is standing at 7.57% during that period while stretching the period over a month that increases to 11.80%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 57.94 which implies that the stock is in neutral territory.
B. Riley Securities downgraded its recommendation for the stock as a “Neutral” from “Buy” on November 16, 2022 while assigning a price target of $44. Cantor Fitzgerald also issued its recommendations for the stock as it downgraded the price target for the stock is $100.
Over the week, SAVA’s stock price is moving 10.26% up while it is -3.41% when we observe its performance for the past one month. Year-to-date it is 30.83% up and over the past year, the stock is showing an upside performance of 40.10%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -0.61 beat the consensus estimate of -0.77 for the same. The company is expected to be releasing its next quarterly report in October, for which analysts forecasted an EPS of -0.88 while estimate for next year EPS is -1.77.
Currently, Cassava Sciences Inc’s total number of outstanding shares is 47.98M. Company’s return on investment (ROI) stands at -8.13% and return on equity (ROE) at -8.35%. Stock’s beta reads -0.59. Stock has a price to book (P/B) ratio of 7.48. Its return on asset (ROA) is -6.97% on average.
